PT Kalbe Farma Tbk Statistics
Want to see PTKFY full AI Analyst Report?
PT Kalbe Farma Tbk (PTKFY) Stock Statistics & Valuation Metrics
Total Valuation
PT Kalbe Farma Tbk has a market cap or net worth of $2.03B. The enterprise value is $1.63B.
- Market Cap
- $2.03B
- Enterprise Value
- $1.63B
Share Statistics
PT Kalbe Farma Tbk has 234,066,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 234,066,960
- Owned by Insiders
- ―
- Owned by Institutions
- 0.03%
Financial Efficiency
PT Kalbe Farma Tbk’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 13.97%.
- Return on Equity (ROE)
- 0.16
- Return on Assets (ROA)
- 0.12
- Return on Invested Capital (ROIC)
- 13.97%
- Return on Capital Employed (ROCE)
- 0.18
- Revenue Per Employee
- 2.75B
- Profits Per Employee
- 285.55M
- Employee Count
- 12,835
- Asset Turnover
- 1.15
- Inventory Turnover
- 3.04
Valuation Ratios
The current PE Ratio of PT Kalbe Farma Tbk is 9.49. PT Kalbe Farma Tbk’s PEG ratio is 1.11.
- PE Ratio
- 9.49
- PS Ratio
- 0.93
- PB Ratio
- 1.42
- Price to FCF
- 12.08
- Price to Operating Cash Flow
- 9.34
- PEG Ratio
- 1.11
Income Statement
In the last 12 months, PT Kalbe Farma Tbk had revenue of 35.32T and earned 3.66T in profits. Earnings per share was 16176.00.
- Revenue
- 35.32T
- Gross Profit
- 14.06T
- Operating Income
- 4.55T
- Pretax Income
- 4.78T
- Net Income
- 3.66T
- EBITDA
- 5.60T
- Earnings Per Share (EPS)
- 16176.00
Cash Flow
In the last 12 months, operating cash flow was 3.88T and capital expenditures -874.56B, giving a free cash flow of 3.00T billion.
- Operating Cash Flow
- 3.88T
- Free Cash Flow
- 3.00T
- Free Cash Flow per Share
- 13078.88
Dividends & Yields
PT Kalbe Farma Tbk pays an annual dividend of $0.22, resulting in a dividend yield of 2.31%
- Dividend Per Share
- $0.22
- Dividend Yield
- 2.31%
- Payout Ratio
- 23.13%
- Free Cash Flow Yield
- 8.28%
- Earnings Yield
- 10.56%
Stock Price Statistics
- Beta
- 0.60
- 52-Week Price Change
- -40.88%
- 50-Day Moving Average
- 8.28
- 200-Day Moving Average
- 9.44
- Relative Strength Index (RSI)
- 59.48
- Average Volume (3m)
- 15.31K
Important Dates
PT Kalbe Farma Tbk upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- Jun 05, 2026
Financial Position
PT Kalbe Farma Tbk as a current ratio of 3.47, with Debt / Equity ratio of 1.28%
- Current Ratio
- 3.47
- Quick Ratio
- 2.16
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.72
- Interest Coverage Ratio
- 128.95
Taxes
In the past 12 months, PT Kalbe Farma Tbk has paid 1.03T in taxes.
- Income Tax
- 1.03T
- Effective Tax Rate
- 0.22
Enterprise Valuation
PT Kalbe Farma Tbk EV to EBITDA ratio is 5.53, with an EV/FCF ratio of 10.34.
- EV to Sales
- 0.80
- EV to EBITDA
- 5.53
- EV to Free Cash Flow
- 10.34
- EV to Operating Cash Flow
- 8.00
Balance Sheet
PT Kalbe Farma Tbk has $5.58T in cash and marketable securities with $295.23B in debt, giving a net cash position of $5.29T billion.
- Cash & Marketable Securities
- $5.58T
- Total Debt
- $295.23B
- Net Cash
- $5.29T
- Net Cash Per Share
- $22.59K
- Tangible Book Value Per Share
- $108.37K
Margins
Gross margin is 37.18%, with operating margin of 12.25%, and net profit margin of 9.84%.
- Gross Margin
- 37.18%
- Operating Margin
- 12.25%
- Pretax Margin
- 12.91%
- Net Profit Margin
- 9.84%
- EBITDA Margin
- 14.42%
- EBIT Margin
- 12.32%
Analyst Forecast
The average price target for PT Kalbe Farma Tbk is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 5.51%
- EPS Growth Forecast
- 3.30%
Scores
- Smart Score
- 3
- AI Score
- 74

